Research Projects & Grants

College/University

  • A Natural History Study of ALS and Other Motor Neuron Disorders-Supplement Award, Role: PD/PI, University of Minnesota, (09/2024 - 08/2027) Status: Awarded
  • A Natural History Study of ALS and Other Motor Neuron Disorders-Prime Award, Role: PD/PI, University of Minnesota, (09/2024 - 08/2027) Status: Awarded

For Profit Organization

  • A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter study to evaluate the safety and efficacy of Ravulizumab in Complement-Inhibitor-Naïve adult patients with Generalized Myasthenia Gravis: Protocol # ALXN1210-MG-306, Role: PI, Alexion Pharmaceuticals, (08/2022 - 08/2023) Status: Completed
  • LONG-TERM FOLLOW-UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT, Role: PI, Genentech, Inc., (01/2024) Status: Approved
  • Oxidative markers and efficacy in Amyotrophic Lateral Sclerosis (ALS) Phenotypes treated with Edaravone, Role: PI, Mitsubishi Tanabe Pharma America, (02/2026 - 02/2027) Status: Approved
  • Oxidative markers and efficacy in Amyotrophic Lateral Sclerosis (ALS) phenotypes treated with Edaravone (Central Monitoring), Role: PI, Mitsubishi Tanabe Pharma America, (07/2025 - 07/2026) Status: Approved
  • A phase 2, randomized, double-blind, placebo-controlled parallel group study ofVHB937 in Amyotrophic Lateral Sclerosis (ALS) over 40 weeks followed by an Open-label Extension (ASTRALS). Protocol: CVHB937B12201, Role: PI, Novartis Pharmaceuticals Corporation, (03/2026 - 03/2027) Status: Approved
  • A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Ocular Myasthenia Gravis., Role: PI, Argenx BV, (02/2026 - 02/2027) Status: Approved

Internal

  • Evaluation of clinical grading scores in motor neuron disease, Role: PI, LLU Dept. of Neurology, (07/2025 - 07/2026) Status: Approved
  • Evaluating multidisciplinary care in the neurology setting, Role: PI, LLU Dept. of Neurology, (04/2023 - 03/2024) Status: Completed
  • Study to Identify Autoantibodies Associated with Amyotrophic Lateral Sclerosis (ALS), Role: PI, LLU Dept. of Neurology, (02/2022) Status: Approved
  • Exploring functional benefits of the mobile arm support for individuals with Amyotrophic lateral sclerosis (ALS), Role: Investigator, LLU Dept. of Occupational Therapy, (03/2018 - 03/2019) Status: Completed
  • Understanding the spectrum of amyotrophic lateral sclerosis, Role: PI, LLU Dept. of Neurology, (02/2026 - 02/2027) Status: Approved

Non-Profit Organization

  • MDA Multidisciplinary Clinic at Loma Linda University Health, Role: PD/PI, Muscular Dystrophy Association, (01/2017 - 06/2027) Status: Awarded
  • Neuromuscular ALS/NMD Program, Role: Principal Investigator, The Community Foundation, (11/2016 - 11/2018) Status: Closed